Actively Recruiting
Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)
Led by Société Française d'Endoscopie Digestive · Updated on 2024-07-30
180
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this prospective, controlled, randomized, multicentre, single-blind study is to compare the rate of intragastric migration of 2 types of esophageal stents with and without an anti-migration device placed for locally advanced or metastatic malignant stenosis of the gastroesophageal junction.
CONDITIONS
Official Title
Anti-Migration System for Anti-reflux Oeso-gastric Stent (ANTIMIG)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient of both sexes aged 18 or over
- Admitted for dysphagia due to locally advanced or metastatic tumoral stenosis of the gastroesophageal junction
- Classified as ASA 1, ASA 2, or ASA 3
- Not participating in another clinical study
- Signed informed consent provided
- Covered by the social security system
You will not qualify if you...
- Stenosis caused by external compression from an extra digestive mass
- Contraindications to procedures needed for stent insertion
- History of mediastinal radiotherapy or esophageal surgery
- Age under 18 or over 90 years
- Classified as ASA 4 or ASA 5
- Pregnant women
- Unable to give personal consent
- No signed informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
French Society of Digestive Endoscopy
Paris, France, 75006
Actively Recruiting
Research Team
D
David KARSENTI, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here